Edgewise Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $10.9M | $285.2M | $15.6M |
| FY2022 | $20.4M | $367.1M | $22.0M |
| FY2023 | $21.2M | $340.0M | $86.1M |
| FY2024 | $27.6M | $486.8M | $41.7M |
| FY2025 | $30.3M | $552.6M | $61.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $10.9M | $285.2M | $15.6M |
| FY2022 | $20.4M | $367.1M | $22.0M |
| FY2023 | $21.2M | $340.0M | $86.1M |
| FY2024 | $27.6M | $486.8M | $41.7M |
| FY2025 | $30.3M | $552.6M | $61.1M |